MedPath

The Impact of the SCN9A Gene Polymorphism on Postoperative Pain

Completed
Conditions
Pain, Postoperative
Pregnancy
Registration Number
NCT02496455
Lead Sponsor
Tokat Gaziosmanpasa University
Brief Summary

The purpose of this study to determine the association between postoperative pain after cesarean section and several single nucleotide polymorphisms in SCN9A sodium channels gene.

Detailed Description

SCN9A gene encodes an alpha subunit of the voltage-gated sodium channel (Nav1.7) and polymorphisms of this gene are associated with severe pain disorders. The impact of the polymorphisms in SCN9A on postoperative pain and opioid consumption after cesarean section is unclear.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • The women aged 18 to 45,
  • in 36 to 40 weeks of pregnancy
  • undergoing cesarean section
Exclusion Criteria
  • History of chronic pain or pain disorders
  • Psychiatric diseases
  • Diabetes mellitus
  • Severe cardiovascular, kidney or liver diseases
  • Alcohol or drug abuse
  • Heavy smoker
  • Unable to use the Patient controlled analgesia (PCA) pump

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Painup to postoperative 24 hours

The pain will be evaluated with the visual analog scale

Secondary Outcome Measures
NameTimeMethod
Opioid consumptionUp to postoperative 24 hours

The total amount of the tramadol administered to the patient will be recorded

Trial Locations

Locations (1)

Gaziosmanpasa University Medical School Hospital

🇹🇷

Tokat, Turkey

Gaziosmanpasa University Medical School Hospital
🇹🇷Tokat, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.